Skribe Raises Pre-Seed Funding to Detect and Prevent Heart Damage during Cancer Treatment
We’re excited to announce the close of our pre-seed round to advance our wireless wearable patch built to detect cardiotoxicity caused by cancer therapies. We’ve found excellent partners in GoAhead Ventures, Marin Sonoma Impact Ventures, and a group of key angel investors – all who recognize the significant opportunity to preserve the heart health of 600,000 Americans […]